Search

Search Constraints

You searched for: Author/Creator Mucciarini, Claudia

Search Results

1. Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancer. (19th March 2019)

2. BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients: Results from a multicenter Italian observational study. (May 2016)

3. Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21). Issue 1 (2nd January 2022)

4. Changes in Cancer Patients' and Caregivers' Disease Perceptions While Receiving Early Palliative Care: A Qualitative and Quantitative Analysis. (29th September 2021)

5. Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer. (February 2016)

6. Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer. (February 2016)

7. Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study). (July 2021)

8. GU-CA-COVID: a clinical audit among Italian genitourinary oncologists during the first COVID-19 outbreak. (October 2021)

9. Incidence and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with metastatic castration-resistant prostate cancer. (November 2020)

10. INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study. (17th October 2018)